This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2024 Dec;13(23):e70350.

doi: 10.1002/cam4.70350.

Correction to "Induction of Resistance to Neurotrophic Tropomyosin-Receptor Kinase Inhibitors by HMGCS2 via a Mevalonate Pathway"

No authors listed

PMID: 39610222
PMCID: PMC11604991
DOI: 10.1002/cam4.70350

Published Erratum

Correction to "Induction of Resistance to Neurotrophic Tropomyosin-Receptor Kinase Inhibitors by HMGCS2 via a Mevalonate Pathway"

No authors listed. Cancer Med. 2024 Dec.

. 2024 Dec;13(23):e70350.

doi: 10.1002/cam4.70350.

PMID: 39610222
PMCID: PMC11604991
DOI: 10.1002/cam4.70350

No abstract available

PubMed Disclaimer

Erratum for

Induction of resistance to neurotrophic tropomyosin-receptor kinase inhibitors by HMGCS2 via a mevalonate pathway.
Kato Y, Matsumoto M, Takano N, Hirao M, Matsuda K, Tozuka T, Onda N, Nakamichi S, Takeuchi S, Miyanaga A, Noro R, Gemma A, Seike M. Kato Y, et al. Cancer Med. 2024 Jun;13(12):e7393. doi: 10.1002/cam4.7393. Cancer Med. 2024. PMID: 38923428 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley